Bio-Techne Corp (TECH)
Days of sales outstanding (DSO)
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 5.90 | 4.80 | 5.20 | 5.68 | 6.40 | |
| DSO | days | 61.91 | 76.02 | 70.15 | 64.23 | 57.00 |
June 30, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.90
= 61.91
The days of sales outstanding (DSO) for Bio-Techne Corp over the specified period demonstrate an overall increasing trend, indicating a gradual elongation in the time taken to collect receivables from customers. As of June 30, 2021, the DSO was 57.00 days, reflecting relatively prompt collections. By June 30, 2022, this figure increased to 64.23 days, suggesting a slight deterioration in receivables collection efficiency. The upward trajectory continued through June 30, 2023, with the DSO reaching 70.15 days, indicative of further extension in collections periods. The trend persisted into June 30, 2024, when the DSO rose to 76.02 days, marking a noteworthy lengthening and potentially pointing to challenges in receivables management or changes in credit policies. However, by June 30, 2025, the DSO decreased to 61.91 days, indicating an improvement in collection performance relative to the previous year. Overall, the fluctuations suggest that while the company experienced periods of extended collection times, recent data reflects some normalization in receivables turnover, though the overall trend from 2021 to 2025 indicates variability in collection efficiency that warrants ongoing monitoring.
Peer comparison
Jun 30, 2025